A new joint laboratory has been opened today in Singapore to develop innovative eye imaging technologies and drug delivery systems. Located on the NTU Smart Campus, the Lab will create technologies using light to image the eye –a technique known as “optical coherence tomography”. One of the Lab’s ventures is the completion of a OCT imaging prototype.
The program would provide a convenient forum for earlier identification of eye conditions, powered by artificial intelligence, without needing attendance at a specialist eye clinic or hospital. These projects will be translated from the lab to the bedside, tested and validated.
The start of the new Lab will also accompany the beginning of ten new projects covering three wide topics, the new development of visual consistency to form new processes of better than before management of diseases and problems, new objects and devices that will help the imaging to diagnose beyond the hospital, into the homes themselves, and multiple form modeling that uses different kinds of screening of image, visual therapeutics that are going to shoot the expansion for groundbreaking plans and also management measures. All these projects will help the formation of many new projects that are going to help the modern development techniques.
Ping’s medical technology department entered into a one year research agreement with the HKU Medical AI Lab Program in May with a view to the clinical evaluation of its retinal disease screening system based on optical coherence tomography.
“Eye disorders tend to be one of the most significant problems for an aging population in Singapore, leading to loss of vision that affects mobility.” In a statement from STANCE Lab, Professor Leopold Schmetterer, Director of STANCE Lab, will develop new imaging technologies for rapidly, effectively, and conveniently detecting and diagnosing eye disorders.